BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 227960)

  • 1. Production of human lymphocyte mediators after activation with periodate or neuraminidase and galactose oxidase.
    Greineder DK; Rocklin RE; David JR
    J Immunol; 1979 Dec; 123(6):2804-7. PubMed ID: 227960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand.
    Center DM; Cruikshank WW; Berman JS; Beer DJ
    J Immunol; 1983 Oct; 131(4):1854-9. PubMed ID: 6352807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
    Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
    J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface glycoproteins of rat lymphocytes. I. Correlation of mitogenic stimulation by periodate or neuraminidase and galactose oxidase with the presence of papain-sensitive glycoproteins.
    Mitchell RN; Bowers WE
    J Immunol; 1978 Dec; 121(6):2181-92. PubMed ID: 214497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galactose oxidase-induced blastogenesis of human lymphocytes and the effect of macrophages on the reaction.
    Biniaminov M; Ramot B; Rosenthal E; Novogrodsky A
    Clin Exp Immunol; 1975 Jan; 19(1):93-8. PubMed ID: 1204241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative pathway induction of T lymphocyte mitogen stimulation.
    Peters JH; Schimmelpfeng L
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):169-82. PubMed ID: 218373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation of human peripheral lymphocytes by galactose oxidase.
    Dixon JF; Parker JW; O'Brien RL
    J Immunol; 1976 Mar; 116(3):575-8. PubMed ID: 1254945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The requirement for macrophage-lymphocyte interaction in T lymphocyte proliferation induced by generation of aldehydes on cell membranes.
    Greineder DK; Rosenthal AS
    J Immunol; 1975 Oct; 115(4):932-8. PubMed ID: 170338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of chronic lymphatic leukaemia cells by pokeweed mitogen after treatment with neuraminidase-galactose oxidase.
    Zafar MN; Pittman S; Cherchi M; Catovsky D
    Clin Exp Immunol; 1981 Apr; 44(1):124-8. PubMed ID: 6973427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of leukocyte migration inhibition factor (LIF) and migration stimulation factor (MStF) by CD4+ and CD8+ human lymphocytes subsets and T-cell clones.
    Méndez-Samperio P; Jiménez-Zamudio L; Favila-Castillo L
    Rev Invest Clin; 1989; 41(2):107-15. PubMed ID: 2675234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A diagnostic assay for the Wiskott-Aldrich syndrome and its variant forms.
    Siminovitch KA; Greer WL; Novogrodsky A; Axelsson B; Somani AK; Peacocke M
    J Investig Med; 1995 Apr; 43(2):159-69. PubMed ID: 7735919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of responding cells in oxidative mitogen stimulation. I. Ia+ cells and Ly-1+2+ cells are required for the proliferative response.
    Phillips ML; Wettstein PJ; O'Brien RL; Parker JW; Frelinger JA
    J Immunol; 1980 Jun; 124(6):2693-9. PubMed ID: 6246169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A).
    Rocklin RE
    J Immunol; 1975 Apr; 114(4):1161-5. PubMed ID: 1090666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor properties of lymphocytes activated by the oxidizing mitogens.
    Wang J; Suthanthiran M; Walle A; Lagman M; Schwartz R; Murthi V; Novogrodsky A; Stenzel KH
    J Immunol; 1986 Jun; 136(12):4735-9. PubMed ID: 3011903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on human migration inhibitory factor: characterization of three molecular species.
    Weiser WY; Greineder DK; Remold HG; David JR
    J Immunol; 1981 May; 126(5):1958-62. PubMed ID: 7012240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of lymphocyte cytotoxicity by modification of the effector or target cells with periodate or with neuraminidase and galactose oxidase.
    Novogrodsky A
    J Immunol; 1975 Mar; 114(3):1089-93. PubMed ID: 163281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of alloimmune memory cells by soluble factors: a model for elicitation of specific allograft responses by immunologically nonspecific signals.
    Suthanthiran M; Rubin AL; Novogrodsky A; Stenzel KH
    Proc Clin Dial Transplant Forum; 1980; 10():207-10. PubMed ID: 6287451
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell surface glycoproteins of rat lymphocytes. II. Protease-sensitive glycoproteins associated with mitogeni stimulation by periodate or neuraminidase plus galactose oxidase.
    Mitchell RN; Bowers WE
    J Immunol; 1980 Jun; 124(6):2632-40. PubMed ID: 6246168
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on leukocyte migration inhibitory factor (LIF) produced by activated T and B cells.
    Szigeti R; Rosén A
    Lymphokine Res; 1988; 7(1):11-20. PubMed ID: 3283466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.